BIO Announces Presenting Companies for 10th Annual BIO Investor Forum

  • Contact: Abigail Hirsch
  • Phone: 202-962-9235
  • Email: ahirsch@bio.org
  • Recommend
  • Tweet
  • Print
  • Email

 

BIO Announces Presenting Companies for 10thAnnual BIO Investor Forum
BIO Investor Forum will be held October 25 – 26 in San Francisco, CA

WASHINGTON, D.C. (September 6, 2011) - The Biotechnology Industry Organization (BIO) today announces the initial selection of presenting companies for the 10th annual BIO Investor Forum to be held October 25 - 26 in San Francisco, CA.  In its 10th year, this international investor conference focused on private and emerging public biotech companies celebrates a “Decade of Excellence.”

“We pride ourselves on creating a unique environment where attendees from around the world come with the purpose of investing in private and early stage biotech companies. It is our hope that with the 10thannual BIO Investor Forum, attendees and presenters alike capitalize on the exceptional opportunities available only at this event,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.

The aim of the forum is to bring together a select group of private and early stage biotech companies and leading investors to foster the development of important new medicines that will expand the industry’s pipeline. Investors attend to meet with executives from life sciences growth companies, benefit from candid panel discussions and get an overview of the industry. Companies attend to meet one-on-one with new and current investors, get the pulse on the latest life science investment trends and network with peers, investors and potential partners.

In addition to the announcement of presenting companies, media and investor registration is now available. Registration is complimentary for credentialed members of the media and qualified investors. To learn more about registration, media please visit hereand investors please visit here.

The criterion for presenting companies was established by BIO and the conference advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech companies.

As of today, the following companies are scheduled to present at this year’s forum:

  • ADVENTRX Pharmaceuticals, Inc., ANX  |  News
  • Aegerion Pharmaceuticals, Inc., News
  • Aeolus Pharmaceuticals, OTC:AOLS  |  News
  • Allon Therapeutics Inc., NPC  |  News
  • Allozyne Inc., News
  • Anacor Pharmaceuticals, Inc., ANAC  |  News
  • Anaphore, Inc., News
  • Anchor Therapeutics, News
  • Ancora Pharmaceuticals Inc., News
  • Aquinox Pharmaceuticals Inc., News
  • Aradigm Corporation, OTC:ARDM  |  News
  • BioSante Pharmaceuticals, Inc., BPAX  |  News
  • Catabasis Pharmaceuticals, Inc., News
  • Catalyst Pharmaceutical Partners, Inc., CPRX  |  News
  • Cell Therapeutics, Inc., CTIC  |  News
  • CoMentis, Inc., News
  • Constellation Pharmaceuticals, News
  • Curis Inc., CRIS  | News
  • Cyclacel Pharmaceuticals, Inc., CYCC  |  News
  • Dicerna Pharmaceuticals, Inc., News
  • Elusys Therapeutics, Inc., News
  • Epizyme, Inc., News
  • FasterCures – Patient Advocacy Group, News
  • Flexion Therapeutics, News
  • GATEKEEPER Pharmaceuticals, News
  • Genocea Biosciences, News
  • GenVec, Inc., GNVC  |  News
  • GlobeImmune Inc., News
  • HemaQuest Pharmaceuticals, Inc., News
  • Heptares Therapeutics, News
  • Ikaria, Inc., News
  • Immune Design Corp., News
  • Immunovaccine Inc., CVE:IMV  |  News
  • Inimex Pharmaceuticals Inc., News
  • Jennerex Biotherapeutics, Inc., News
  • KAI Pharmaceuticals, Inc., News
  • Kiadis Pharma, News
  • KineMed, Inc., News
  • LigoCyte Pharmaceuticals, Inc., News
  • Lipocine Inc., News
  • MabVax Therapeutics, Inc., News
  • MaxCyte, Inc., News
  • Mersana Therapeutics, Inc., News
  • Mirna Therapeutics Inc., News
  • Mithridion, Inc., News
  • Peregrine Pharmaceuticals, Inc., PPHM  |  News
  • PLx Pharma Inc., News
  • Probiodrug AG, News
  • Prosensa Therapeutics, News
  • Reata Pharmaceuticals Inc., News
  • Resverlogix Corp., RVX  |  News
  • Rib-X Pharmaceuticals, Inc., News
  • RXi Pharmaceuticals Corporation, RXII  |  News
  • Savara Inc., News
  • Senesco Technologies, Inc., SNT  |  News
  • Sorbent Therapeutics, Inc., News
  • Spinifex Pharmaceuticals, News
  • SuppreMol GmbH, News
  • Syndax Pharmaceuticals, Inc., News
  • Syntaxin Ltd., News
  • TESARO, News
  • Tetraphase Pharmaceuticals, News
  • Tobira Therapeutics, News
  • Tranzyme Pharma, TZYM  |  News
  • Trius Therapeutics, TSRX  |  News
  • Unigene Laboratories, Inc., OTC:UGNE  |  News
  • XOMA LLC, XOMA  |  News
  • Zalicus Inc., ZLCS  |  News
  • ZIOPHARM Oncology Inc., ZIOP  |  News
  • Zymeworks Inc., News

With the success of last year’s inaugural “Discovery Track,” BIO is pleased to announce the return of this program. “Discovery Track” features a select group of entrepreneurs who are first introducing their startup companies to the national investment community at the BIO Investor Forum. The following companies are scheduled to present:
 

  • A&G Pharmaceutical, Inc., News
  • Aciont Inc., News
  • Afraxis, News
  • Arbovax, Inc., News
  • Axikin Pharmaceuticals, News
  • Cebix Incorporated, News
  • CureFAKtor Pharmaceuticals, LLC, News
  • Cyterix Pharmaceuticals, Inc., News
  • Del Mar Pharmaceuticals, News
  • DLVR Therapeutics Inc., News
  • DNA Therapeutics SA, News
  • Edge Therapeutics, Inc., News
  • Envoy Therapeutics, News
  • Epiomed Therapeutics, Inc., News
  • Esperion Therapeutics, Inc., News
  • FluGen, Inc., News
  • Genprex, Inc., News
  • GlycoRegImmune, Inc., News
  • G-Zero Therapeutics, News
  • Immune Targeting Systems Ltd., News
  • ImmunoGenes AG, News
  • ImmusanT, Inc., News
  • Indel Therapeutics Inc., News
  • InVasc Therapeutics, Inc., News
  • Kareus Therapeutics, SA, News
  • Molecular Templates Inc., News
  • PharmaNeuroBoost, News
  • Sirius Genomics Inc., News
  • TxCell S.A., News

Check back often as new presenters are continuously being added. If you are interested in becoming a presenter, please submit an application here.

Upcoming BIO Events

BIO India International Partnering Conference
September 21-22, 2011
Hyderabad, India

BIO China International Conference
October 12-13, 2011
Shanghai, China

10th Annual BIO Investor Forum
October 25-26, 2011
San Francisco, Calif.

BIO-Europe 2011
October 31-November 2, 2011
Duesseldorf, Germany

BIO IP Counsels Committee Fall Conference & Meeting

November 2-4, 2011

New York, NY

BioMalaysia 2011 Conference & Exhibition/
2011 Pacific Rim Summit on Industrial Biotechnology and Bioenergy

November 21-23, 2011
Kuala Lumpur, Malaysia

For more information:
Visit http://www.bio.org
Follow us on Twitter @IAmBiotech
Join us on LinkedIn/MyBio
Become a fan at facebook.com/IAmBiotech

###

  

About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.